Woodline Partners LP Has $4.66 Million Holdings in LifeStance Health Group, Inc. (NASDAQ:LFST)

Woodline Partners LP lessened its holdings in LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) by 52.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 632,301 shares of the company's stock after selling 691,089 shares during the period. Woodline Partners LP owned about 0.17% of LifeStance Health Group worth $4,660,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of the business. Vanguard Group Inc. boosted its position in shares of LifeStance Health Group by 7.9% in the fourth quarter. Vanguard Group Inc. now owns 10,689,396 shares of the company's stock worth $78,781,000 after buying an additional 784,818 shares during the period. Jennison Associates LLC boosted its position in shares of LifeStance Health Group by 278.4% in the fourth quarter. Jennison Associates LLC now owns 8,086,380 shares of the company's stock worth $59,597,000 after buying an additional 5,949,438 shares during the period. Wellington Management Group LLP boosted its position in shares of LifeStance Health Group by 9.2% in the fourth quarter. Wellington Management Group LLP now owns 5,276,237 shares of the company's stock worth $38,886,000 after buying an additional 445,796 shares during the period. Dimensional Fund Advisors LP boosted its position in shares of LifeStance Health Group by 87.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,524,529 shares of the company's stock worth $25,977,000 after buying an additional 1,643,390 shares during the period. Finally, Geode Capital Management LLC boosted its position in shares of LifeStance Health Group by 0.4% in the fourth quarter. Geode Capital Management LLC now owns 3,465,471 shares of the company's stock worth $25,546,000 after buying an additional 13,293 shares during the period. Institutional investors and hedge funds own 85.50% of the company's stock.

Insider Activity at LifeStance Health Group

In other LifeStance Health Group news, insider Lisa K. Miller sold 18,845 shares of the business's stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $6.90, for a total value of $130,030.50. Following the completion of the sale, the insider now owns 339,810 shares of the company's stock, valued at $2,344,689. The trade was a 5.25% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 3.20% of the company's stock.

Analyst Upgrades and Downgrades

Several analysts have recently commented on LFST shares. William Blair reaffirmed an "outperform" rating on shares of LifeStance Health Group in a research report on Friday, February 28th. Canaccord Genuity Group assumed coverage on LifeStance Health Group in a research report on Thursday, April 3rd. They set a "buy" rating and a $8.00 price objective for the company. KeyCorp assumed coverage on LifeStance Health Group in a research report on Tuesday, April 8th. They set an "overweight" rating and a $9.00 price objective for the company. Finally, UBS Group raised LifeStance Health Group from a "neutral" rating to a "buy" rating and set a $8.50 price objective for the company in a research report on Tuesday. One equities research analyst has rated the stock with a sell rating, four have assigned a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, LifeStance Health Group currently has a consensus rating of "Moderate Buy" and an average price target of $8.50.

LifeStance Health Group Stock Down 1.2%

LFST traded down $0.08 during trading on Thursday, reaching $5.97. 613,171 shares of the stock traded hands, compared to its average volume of 1,585,047. The stock has a market cap of $2.32 billion, a price-to-earnings ratio of -22.90 and a beta of 1.30. LifeStance Health Group, Inc. has a fifty-two week low of $4.64 and a fifty-two week high of $8.61. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.32 and a quick ratio of 1.32. The stock's 50-day simple moving average is $6.35 and its two-hundred day simple moving average is $7.15.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.